Serum resistin is not associated with obesity or insulin resistance in humans

European Review for Medical and Pharmacological Sciences

Volumn 9, Issue 3, 2005, Pages 161-165

  Iqbal, N ^a,b   Seshadri, P ^a,b   Stern, L ^a   Loh, J ^b   Kundu, S ^c   Jafar, T ^d   Samaha, F F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Diet; Insulin; Obesity; Resistin; Weight loss

Indexed keywords

GLUCOSE; INSULIN; RESISTIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONES, ECTOPIC; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RESISTIN;

EID: 22144482320     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Steppan C, Bailey S, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
2. Steppan CM, Lazar MA. Resistin and obesity associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
3. Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2001; 276: 25651-25653.
4. Fukui Y, Motojima K. Expression of resistin in adipose tissue is modulated by various factors including peroxisome proliferator-activated receptor alpha. Diabetes Obes Metab 2002; 4: 342-345.
5. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross sectional and interventional studies in normal, insulin resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848-4856.
6. Heilbronn LK, Road J, Janderova L, et al. Relationship between serum resistin concentration and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004; 84: 1844-1848.
7. Stern L, Iqbal N, Seshadri P, et al. The effects of low carbohydrate versus conventional weight loss diets in severely obese adults: One year follow-up of a randomized trial. Ann Intern Med 2004; 140: 778-785.
8. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003; 348: 2074-2081.
9. NHLBI, NIDDK. Obesity education initiative. In: Clinical Guidelines on the Identification, Education, and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication no. 98-4083. Bethedsa, MD: NHBLI in cooperation with the NIDDK; 1998.
10. Karvetti RL, Knits LR. Validity of the 24-hour diet recall. Am J Diet Assoc 1985; 85: 1437-1442.
11. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Norwalk, Conn.: Appleton and Lange, 1990.
12. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285: 561-564.
13. Pfutzer A, Laangenfeld, M, Kunt T, Lobig M, Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance; Evaluation studies. Clinical Lab 2003; 49: 571-576.
14. Fain JN, Cheema PS, Bahouth SW, et al. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003; 300: 674-678.